Dan is Vice President of European Manufacturing for Adaptimmune, responsible for the manufacture of lentivirus (used for ex vivo modification of autologous cells) and iPSC-derived allogeneic enhanced Tcells, both within internal facilities the UK, the later where he was the lead in the design and creation of a new dedicated facility. He has worked for Adaptimmune for 4 years, previously as Senior Director of UK Quality. Prior to joining Adaptimmune, Dan was Global Director of Supplier Quality Assurance for Catalent Pharma Solutions partnering with Procurement on risk reduction in the supply chain and overall has a career of 20 years in pharmaceutical manufacture and distribution.